These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2523634)

  • 1. Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy.
    Leier CV; Binkley PF; Starling RC; Huss-Randolph P
    Am Heart J; 1989 May; 117(5):1092-8. PubMed ID: 2523634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group.
    Narahara KA
    Am Heart J; 1991 May; 121(5):1471-9. PubMed ID: 1826806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure.
    Choraria SK; Taylor D; Pilcher J
    Circulation; 1987 Dec; 76(6):1307-11. PubMed ID: 2960473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure.
    Zipperle G; Butzer F; Dieterich HA; Heinrich F
    Am J Cardiol; 1987 Aug; 60(5):72C-74C. PubMed ID: 2956873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    Am J Cardiol; 1987 Aug; 60(5):68C-71C. PubMed ID: 2956872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with oral enoximone for chronic congestive heart failure: the European experience.
    Treese N; Erbel R; Pilcher J; Choraria S; Rhein S; Dieterich HA; Meyer J
    Am J Cardiol; 1987 Aug; 60(5):85C-90C. PubMed ID: 2956876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure.
    Klauss V; Zwehl W; Mudra H; Huber R; Schmidt R; Scheininger M; Vogler A; Tschaidse O; Dieterich HA; Theisen K
    Klin Wochenschr; 1991 Jul; 69(10):430-5. PubMed ID: 1719270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, randomised, cross-over comparison of oral captopril and enoximone added to diuretic treatment in patients with severe heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):45-50. PubMed ID: 2450255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment.
    Dubourg O; Delorme G; Hardy A; Beauchet A; Tarral A; Bourdarias JP
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S33-42; discussion S43. PubMed ID: 2145237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enoximone in patients with heart failure uncontrolled by captopril and diuretics.
    Cowley AJ; Stainer K; Fullwood L; Muller AF; Hampton JR
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S45-52; discussion 52-3. PubMed ID: 2145238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study.
    Leier CV; Lima JJ; Meiler SE; Unverferth DV
    Am Heart J; 1988 May; 115(5):1051-9. PubMed ID: 2966546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure.
    Leier CV; Meiler SE; Matthews S; Unverferth DV
    Am J Cardiol; 1987 Aug; 60(5):27C-30C. PubMed ID: 2956864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
    Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
    Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic therapy of severe heart failure with enoximone.
    Gilfrich HJ; Witzke-Gross J; Römer A
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S75-7. PubMed ID: 2480490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
    Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
    Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of captopril and enoximone in patients with severe heart failure: a placebo controlled double-blind study.
    Cowley AJ; Stainer K; Wynne RD; Rowley JM; Hampton JR
    Int J Cardiol; 1989 Sep; 24(3):311-6. PubMed ID: 2527829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis.
    Herrmann HC; Ruddy TD; William G; Strauss HW; Boucher CA; Fifer MA
    J Am Coll Cardiol; 1987 May; 9(5):1117-23. PubMed ID: 2952702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group.
    Lowes BD; Higginbotham M; Petrovich L; DeWood MA; Greenberg MA; Rahko PS; Dec GW; LeJemtel TH; Roden RL; Schleman MM; Robertson AD; Gorczynski RJ; Bristow MR
    J Am Coll Cardiol; 2000 Aug; 36(2):501-8. PubMed ID: 10933364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.
    Uretsky BF; Jessup M; Konstam MA; Dec GW; Leier CV; Benotti J; Murali S; Herrmann HC; Sandberg JA
    Circulation; 1990 Sep; 82(3):774-80. PubMed ID: 2144216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
    Gilbert EM; Bristow MR; Mason JW
    Am J Cardiol; 1987 Aug; 60(5):57C-62C. PubMed ID: 2956870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.